Home » Topics » Regulatory

Regulatory
RSS

Roche granted additional exclusivity for Versed from FDA

Oct. 23, 1998

Phase III trial of Nutropin Depot successfully completed; NDA filing slated for 1999

Oct. 23, 1998

Tacalcitol lotion equivalent to ointment in animal study

Oct. 23, 1998

Fexofenadine in the treatment of chronic idiopathic urticaria

Oct. 22, 1998

Versed Syrup approved for pediatric sedation

Oct. 21, 1998

Yamanouchi applies for approval of oral bisphosphonate in Japan

Oct. 21, 1998

Yamanouchi introduces novel formulation of antiemetic drug

Oct. 20, 1998

Verapamil recommended for first-line treatment of cluster headache

Oct. 19, 1998

First FDA approval for once-daily use of an inhaled corticosteroid for asthma

Oct. 16, 1998

Taxol combination therapy approved in France for NSCLC indication

Oct. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...